VASCULAR ACCESS SITE SWELLING

This adverse event was reported 44 times

These drugs are most commonly taken by patients reporting VASCULAR ACCESS SITE SWELLING:

# Drug Count
0 OCRELIZUMAB 5
1 CARBOPLATIN 4
2 ALENDRONATE SODIUM 3
3 CYCLOBENZAPRINE 3
4 DULAGLUTIDE 3
5 EMPAGLIFLOZIN 3
6 FLUOROURACIL 3
7 FLUOROURACIL CREAM, 0.5% 3
8 GABAPENTIN 3
9 INSULIN GLARGINE 3
See all common drugs associated with VASCULAR ACCESS SITE SWELLING

VASCULAR ACCESS SITE SWELLING is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MIFEPRISTONE 3 0.0006
1 ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL 1 0.0006
2 PASIREOTIDE 1 0.0004
3 PRUCALOPRIDE 1 0.0004
4 ETEPLIRSEN 1 0.0004
5 DANAZOL 1 0.0004
6 LANADELUMAB-FLYO 1 0.0003
7 C1 ESTERASE INHIBITOR RECOMBINANT 2 0.0003
8 FEXOFENADINE HCL 1 0.0003
9 GEMTUZUMAB OZOGAMICIN 1 0.0003
See all drugs enriched for association with VASCULAR ACCESS SITE SWELLING